CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
4.310
+0.100 (2.38%)
Dec 24, 2025, 4:00 PM EST - Market closed
CureVac Market Cap
CureVac has a market cap or net worth of $970.53 million as of December 24, 2025. Its market cap has increased by 39.57% in one year.
Market Cap
970.53M
Enterprise Value
500.96M
1-Year Change
39.57%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $970.53M, a decrease of -90.13%. That is a compound annual growth rate of -35.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 948.01M | 23.94% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
| Aug 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |